Vairavan Latha
- SEC CIK
- 0002065881
In the past year, 5 open-market sale filings worth $148.5K and no purchases.
Current role at each company
- ARQT Arcutis Biotherapeutics, Inc.SVP Chief Financial Officeras of May 13, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $148.5K
- 5 filings
- Net
- −$148.5K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Vairavan Latha as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 13, 2026 (view filing) | May 11 | 2 days | Vairavan LathaSVP Chief Financial Officer | SSale | −435 | $21.05 | −$9.16K | −0.5%86.0K after | 10b5-1 |
| May 6, 2026 (view filing) | May 4 | 2 days | Vairavan LathaSVP Chief Financial Officer | SSale | −1.34K | $23.61 | −$31.7K | −1.5%86.4K after | 10b5-1 |
| Mar 3, 2026 (view filing) | Mar 2 | 1 day | Vairavan LathaSVP Chief Financial Officer | SSale | −2.85K | $25.18 | −$71.8K | −3.1%87.8K after | 2 lots10b5-1 |
| Feb 4, 2026 (view filing) | Feb 2 | 2 days | Vairavan LathaSVP Chief Financial Officer | SSale | −1.32K | $25.50 | −$33.7K | −2.0%63.6K after | 10b5-1 |
| Nov 5, 2025 (view filing) | Nov 3 | 2 days | Vairavan LathaSVP Chief Financial Officer | SSale | −88 | $24.72 | −$2.18K | −0.1%64.9K after | 10b5-1 |
| Aug 5, 2025 (view filing) | Aug 4 | 1 day | Vairavan LathaSVP Chief Financial Officer | SSale | −89 | $14.33 | −$1.28K | −0.1%65.0K after | 10b5-1 |